Connection

NEAL KLEIMAN to Fibroblast Growth Factor 2

This is a "connection" page, showing publications NEAL KLEIMAN has written about Fibroblast Growth Factor 2.
Connection Strength

0.050
  1. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002 Feb 19; 105(7):788-93.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.